title: Plasma polymerised polyoxazoline thin films for biomedical applications.
abstract: Poly(2-oxazoline)s are emerging revolutionary biomaterials, exhibiting comparable and even superior properties to well-established counterparts. Overcoming current tedious wet synthesis methods, we report solvent-free and substrate independent, plasma polymerised nanoscale biocompatible polyoxazoline coatings capable of controlling protein and cell adhesion, and significantly reducing biofilm build up.
authors: Mawson Institute, UniSA, Mawson Lakes, SA 5095, Australia. krasimir.vasilev@unisa.edu.au.
authors: M N
authors: MN
authors: Ramiasa
authors: A A
authors: AA
authors: Cavallaro
authors: A
authors: A
authors: Mierczynska
authors: S N
authors: SN
authors: Christo
authors: J M
authors: JM
authors: Gleadle
authors: J D
authors: JD
authors: Hayball
authors: K
authors: K
authors: Vasilev
mesh_terms: D001672:Biocompatible Materials / Q000737:chemistry* / Q000494:pharmacology; D002448:Cell Adhesion; D002470:Cell Survival; D002478:Cells, Cultured; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects; D010080:Oxazoles / Q000737:chemistry* / Q000494:pharmacology; D011073:Polyamines / Q000737:chemistry; D058105:Polymerization; D012710:Serum Albumin, Bovine / Q000737:chemistry; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D001672:Biocompatible Materials; C508600:IL6 protein, human; D015850:Interleukin-6; D010080:Oxazoles; D011073:Polyamines; D014409:Tumor Necrosis Factor-alpha; C577913:poly(2-oxazoline); D012710:Serum Albumin, Bovine; C063994:polyallylamine